The international race for Coronavirus vaccines continues. This Monday, November 9, the two laboratories Pfizer and Biontech affirmed that the vaccine against Covid-19 that they have developed is “90% effective”, to prevent infections. For the moment, these are preliminary results, carried out at the end of a large-scale phase 3 trial underway, the last step before an application for approval. It must be said that this news brings a wave of hope to countries around the world, as the pandemic continues to infect and kill thousands of people every day.
“More than eight months after the start of the worst pandemic in more than a century, we believe that this step represents a significant step forward for the world in our battle against Covid-19”, the president said via a statement. – CEO of the American giant Pfizer, Albert Bourla. A true world leader in the field of pharmacy, Pfizer is an American pharmaceutical company, founded in 1849. The company was originally started by two young German immigrants, Charles Pfizer and his cousin Charles Erhart.
A doctorate in veterinary medicine
Now, the American giant is headed by its 58-year-old CEO, Albert Bourla, who succeeded Ian Read, since January 1, 2019. Previously, Albert Bourla was Pfizer’s chief operating officer. Born in Greece to a Jewish family, he discovered the medical world by first becoming a veterinarian. In his early years, he completed a doctorate in reproductive biotechnology at the prestigious Aristotle University in Thessaloniki, Greece. Albert Bourla joined the Pfizer group in 1993, first as a doctor of veterinary medicine and technical director of the Animal Health Division in his country. Its rise was meteoric in the 2000s, a decade during which Albert Bourla held several executive roles within several divisions of the group. He is also a member of several boards, including the Business Council and the Business Roundtable.
Albert Bourla © © Mega